Under the lead of Munich partner Dr Philipp Grzimek, GÖRG advised the founder and managing shareholder of Plantafood Medical, Manfred Scheffler, on investment by IBEX Wachstumspartner (IBEX).
Plantafood Medical is a leading company in the research, development, and production of dietary supplements and is among the market leaders in Germany for health-oriented combination preparations. Founded in 2001 by Manfred Scheffler, Plantafood Medical develops and manufactures specialised dietary supplements in various dosage forms for numerous national and international supplement brands with a team of over 120 employees in Germany.
IBEX is an owner-managed investment company focusing on succession solutions in the German mid-market. Its emphasis is on management buy-ins and internal management successions. By investing in Plantafood Medical, IBEX ensures the company's successful further development and positions it for continued growth.
GÖRG comprehensively advised the founder and managing shareholder of Plantafood Medical, Manfred Scheffler, throughout this transaction, providing support in all legal and tax-related matters.
Advisor to the Managing Shareholder (Plantafood Medical)
GÖRG Partnerschaft von Rechtsanwälten mbB
Dr Philipp Grzimek, LL.M. (Lead, Partner, Corporate Law/M&A, Munich)
Dr Bernhard A. Guthy, LL.M. (Partner, Corporate Law/M&A, Munich)
Jonas Böttger (Associate, Corporate Law/M&A, Munich)
Madeleine Schwall (Associate, Corporate Law/M&A, Munich)
Michael Gierth (Partner, Real Estate Law, Munich)
Adrian Grüner (Senior Associate, Real Estate Law, Munich)
Dr Thomas Lange (Partner, Financing, Cologne)
Dr Kai Tumbrägel, LL.M. (Partner, Commercial, Cologne)
Dr Ricardo Vocke-Kerkhof (Senior Associate, Commercial, Cologne)
Nora Dibbert (BWLS, Tax Law, Hamburg)
